Sysmex Co. (OTCMKTS:SSMXY) Sees Large Increase in Short Interest

Sysmex Co. (OTCMKTS:SSMXY - Get Free Report) was the target of a large increase in short interest in April. As of April 15th, there was short interest totalling 73,300 shares, an increase of 633.0% from the March 31st total of 10,000 shares. Based on an average trading volume of 192,200 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.0% of the company's stock are short sold.

Sysmex Stock Down 1.4 %

OTCMKTS SSMXY traded down $0.27 during trading hours on Thursday, hitting $18.19. The company's stock had a trading volume of 59,019 shares, compared to its average volume of 68,523. Sysmex has a 52 week low of $14.38 and a 52 week high of $22.00. The company has a market capitalization of $11.45 billion, a PE ratio of 36.87 and a beta of 1.08. The company has a current ratio of 3.19, a quick ratio of 2.42 and a debt-to-equity ratio of 0.11. The company's 50-day simple moving average is $18.60 and its two-hundred day simple moving average is $18.91.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $0.17 earnings per share for the quarter. Research analysts anticipate that Sysmex will post 0.57 EPS for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.